Search

Displaying results 7511 - 7520 of 8967 in total
  1. Drug

    Elvucitabine

    go.drugbank.com/drugs/DB06236
    Investigational

  2. Drug

    (6R)-Folinic acid

    go.drugbank.com/drugs/DB03256
    Experimental

    Mixtures: FERPLEX FOL, FERPLEX FOL
  3. Drug

    Tosedostat

    go.drugbank.com/drugs/DB11781
    Investigational

    Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the M1 family of aminopeptidases, in pa...

  4. Drug

    Desoxycortone

    go.drugbank.com/drugs/DB15972
    Experimental

    Categories: Corticosteroids for Systemic Use, Corticosteroids for Systemic Use, Plain
  5. Drug

    Epicillin

    go.drugbank.com/drugs/DB13300
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  6. Drug

    PF-04634817

    go.drugbank.com/drugs/DB14955
    Investigational

    PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).

  7. Drug

    XmAb24306

    go.drugbank.com/drugs/DB17526
    Investigational

    It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.

  8. Drug

    Deferitrin

    go.drugbank.com/drugs/DB16132
    Investigational

    Deferitrin is under investigation in clinical trial NCT00069862 (Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-thalassemia).

  9. Drug

    Tropifexor

    go.drugbank.com/drugs/DB16343
    Investigational

    Tropifexor is under investigation in clinical trial NCT02516605 (A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients).

  10. Drug

    Mezagitamab

    go.drugbank.com/drugs/DB16370
    Investigational

    Mezagitamab is under investigation in clinical trial NCT04278924 (Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/chronic Primary Immune Thrombocytopenia